Medicare Enrolled

Dr. Michael Schweitz, M.D.

Rheumatology · West Palm Beach, FL
Consulting-driven
1411 N FLAGLER DR, West Palm Beach, FL 33401
5616594242
In practice since 2005 (20 years)
NPI: 1700886371 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Schweitz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Schweitz? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Schweitz

Dr. Michael Schweitz is a rheumatology in West Palm Beach, FL, with 20 years in practice.

Between the years covered by Open Payments, Dr. Schweitz received a total of $64,808 from 32 pharmaceutical and/or device companies across 656 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Schweitz is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice$ $64,808 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$64,808
Total received (2018-2024)
Avg $9,258/year across 7 years
Top 10% in FL for rheumatology
32
Companies
656
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$41,745 (64.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,981 (20.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$10,081 (15.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$150
2023
$18
2022
$133
2021
$11,718
2020
$20,573
2019
$10,246
2018
$21,970

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
United Rheumatology
$41,745
Genentech USA, Inc.
$10,135
Janssen Biotech, Inc.
$2,613
Amgen Inc.
$2,359
UCB, Inc.
$1,376
E.R. Squibb & Sons, L.L.C.
$1,319
PFIZER INC.
$873
Johnson & Johnson Health Care Systems Inc.
$872
AbbVie, Inc.
$481
GlaxoSmithKline, LLC.
$472
Radius Health, Inc.
$430
AbbVie Inc.
$365
Lilly USA, LLC
$348
Mallinckrodt LLC
$166
SANOFI-AVENTIS U.S. LLC
$159
Horizon Therapeutics plc
$142
GENZYME CORPORATION
$141
Celgene Corporation
$137
Novartis Pharmaceuticals Corporation
$117
Genentech, Inc.
$110
Horizon Pharma plc
$86
Sobi, Inc
$86
SOBI, INC
$78
ABBVIE INC.
$49
Merck Sharp & Dohme Corporation
$26
Boehringer Ingelheim Pharmaceuticals, Inc.
$24
Orthogenrx Inc.
$19
FIDIA PHARMA USA INC.
$19
Aurinia Pharma U.S., Inc.
$18
Bioventus LLC
$17
Ironwood Pharmaceuticals, Inc
$13
Takeda Pharmaceuticals U.S.A., Inc.
$12
Top 3 companies account for 84.1% of total payments
Associated products mentioned in payments ›
ACTHAR · Actemra · BENLYSTA · COLOGUARD DNA CAPTURE REAGENTS · COSENTYX · Cimzia · DUEXIS · DUZALLO · EVENITY · Enbrel · FORTEO · GELSYN 3 · GenVisc 850 · Humira · Hymovis · ILARIS · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · OFEV · OLUMIANT · ORENCIA · Otezla · Prolia · REMICADE · RENFLEXIS · RINVOQ · Rinvoq · Rituxan · SILTEX Breast Implants · SIMPONI ARIA · STELARA · TALTZ · TREMFYA · Tymlos · Uloric · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (64%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 10% for rheumatology in FL.

Looking for a rheumatology in West Palm Beach?
Compare rheumatologys in the West Palm Beach area by procedure volume, costs, and industry payment transparency.
Browse rheumatologys nearby

Geographic Context

Rheumatologys within 10 mi
43
Per 100K population
2.9
County median income
$81,115
Nearest hospital
GOOD SAMARITAN MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry✓ NPPESWeekly updates
Medicare Enrollment✓ PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments✓ Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Schweitz is a rheumatology, and high industry engagement (consulting-driven, top 10%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Schweitz receive payments from pharmaceutical companies?
Yes. Dr. Schweitz received a total of $64,808 from 32 companies across 656 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Schweitz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Rheumatologys in West Palm Beach
Browse rheumatologys in West Palm Beach ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologys in FL
Rheumatologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologys in FL
Which FL rheumatologys receive the most from drug and device companies.
By company
United Rheumatology Payments to Doctors
See all physicians who received payments from United Rheumatology.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc..
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →